Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination

IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES
Elena Varea-Jiménez , Esteban Aznar Cano , Lorena Vega-Piris , Elena Vanessa Martínez Sánchez , Clara Mazagatos , Lucía García San Miguel Rodríguez-Alarcón , Inmaculada Casas , María José Sierra Moros , Maria Iglesias-Caballero , Sonia Vazquez-Morón , Amparo Larrauri , Susana Monge , the Working group for the surveillance and control of COVID-19 in Spain* and RELECOV**
{"title":"Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination","authors":"Elena Varea-Jiménez ,&nbsp;Esteban Aznar Cano ,&nbsp;Lorena Vega-Piris ,&nbsp;Elena Vanessa Martínez Sánchez ,&nbsp;Clara Mazagatos ,&nbsp;Lucía García San Miguel Rodríguez-Alarcón ,&nbsp;Inmaculada Casas ,&nbsp;María José Sierra Moros ,&nbsp;Maria Iglesias-Caballero ,&nbsp;Sonia Vazquez-Morón ,&nbsp;Amparo Larrauri ,&nbsp;Susana Monge ,&nbsp;the Working group for the surveillance and control of COVID-19 in Spain* and RELECOV**","doi":"10.1016/j.eimc.2022.11.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>This study compares the severity of SARS-CoV-2 infections caused by Alpha, Delta or Omicron variants in periods of co-circulation in Spain, and estimates the variant-specific association of vaccination with severe disease.</p></div><div><h3>Methods</h3><p>SARS-CoV-2 infections notified to the national epidemiological surveillance network with information on genetic variant and vaccination status were considered cases if they required hospitalisation or controls otherwise. Alpha and Delta were compared during June–July 2021; and Delta and Omicron during December 2021–January 2022. Adjusted odds ratios (aOR) were estimated using logistic regression, comparing variant and vaccination status between cases and controls.</p></div><div><h3>Results</h3><p>We included 5,345 Alpha and 11,974 Delta infections in June–July and 5,272 Delta and 10,578 Omicron in December–January. Unvaccinated cases of Alpha (aOR: 0.57; 95% CI: 0.46–0.69) or Omicron (0.28; 0.21–0.36) had lower probability of hospitalisation vs. Delta. Complete vaccination reduced hospitalisation, similarly for Alpha (0.16; 0.13–0.21) and Delta (June–July: 0.16; 0.14–0.19; December–January: 0.36; 0.30–0.44) but lower from Omicron (0.63; 0.53–0.75) and individuals aged 65+ years.</p></div><div><h3>Conclusion</h3><p>Results indicate higher intrinsic severity of the Delta variant, compared with Alpha or Omicron, with smaller differences among vaccinated individuals. Nevertheless, vaccination was associated to reduced hospitalisation in all groups.</p></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 4","pages":"Pages 187-194"},"PeriodicalIF":2.6000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722675/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213005X22002816","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

This study compares the severity of SARS-CoV-2 infections caused by Alpha, Delta or Omicron variants in periods of co-circulation in Spain, and estimates the variant-specific association of vaccination with severe disease.

Methods

SARS-CoV-2 infections notified to the national epidemiological surveillance network with information on genetic variant and vaccination status were considered cases if they required hospitalisation or controls otherwise. Alpha and Delta were compared during June–July 2021; and Delta and Omicron during December 2021–January 2022. Adjusted odds ratios (aOR) were estimated using logistic regression, comparing variant and vaccination status between cases and controls.

Results

We included 5,345 Alpha and 11,974 Delta infections in June–July and 5,272 Delta and 10,578 Omicron in December–January. Unvaccinated cases of Alpha (aOR: 0.57; 95% CI: 0.46–0.69) or Omicron (0.28; 0.21–0.36) had lower probability of hospitalisation vs. Delta. Complete vaccination reduced hospitalisation, similarly for Alpha (0.16; 0.13–0.21) and Delta (June–July: 0.16; 0.14–0.19; December–January: 0.36; 0.30–0.44) but lower from Omicron (0.63; 0.53–0.75) and individuals aged 65+ years.

Conclusion

Results indicate higher intrinsic severity of the Delta variant, compared with Alpha or Omicron, with smaller differences among vaccinated individuals. Nevertheless, vaccination was associated to reduced hospitalisation in all groups.

[由阿尔法型、德尔塔型或奥米克隆型 SARS-CoV-2 变体引起的 COVID-19 病例的严重程度比较及其与疫苗接种的关系]。
背景:本研究比较了西班牙共同流行期间由 Alpha、Delta 或 Omicron 变种引起的 SARS-CoV-2 感染的严重程度,并估算了接种疫苗与严重疾病之间的特定变异关系:向国家流行病学监测网络通报的 SARS-CoV-2 感染病例,如果需要住院治疗,则被视为病例;如果不需要住院治疗,则被视为对照组。在 2021 年 6 月至 7 月期间,对 Alpha 和 Delta 进行比较;在 2021 年 12 月至 2022 年 1 月期间,对 Delta 和 Omicron 进行比较。使用逻辑回归法估算了病例和对照组之间的调整后患病率(aOR),比较了病例和对照组之间的变异和疫苗接种情况:我们纳入了 6 月至 7 月的 5,345 例 Alpha 型和 11,974 例 Delta 型感染病例,以及 12 月至 1 月的 5,272 例 Delta 型和 10,578 例 Omicron 型感染病例。未接种疫苗的阿尔法病例(aOR:0.57;95% CI:0.46-0.69)或奥米克隆病例(0.28;0.21-0.36)与德尔塔病例相比,住院概率较低。完全接种疫苗可降低住院率,阿尔法(0.16;0.13-0.21)和德尔塔(6-7 月:0.16;0.14-0.19;12-1 月:0.36;0.30-0.44)的情况类似,但奥米克龙(0.63;0.53-0.75)和 65 岁以上人群的住院率较低:结果表明,与阿尔法或奥米克龙变体相比,德尔塔变体的内在严重性更高,但接种疫苗者之间的差异较小。尽管如此,接种疫苗还是减少了所有群体的住院率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
8.00%
发文量
194
审稿时长
29 days
期刊介绍: Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信